Is MDT Stock Undervalued?
A comprehensive valuation analysis of Medtronic PLC (MDT) examining current multiples, intrinsic value, and comparing to analyst expectations.
Valuation Verdict
Potentially Undervalued
89341051529.8% upside potential
Based on our analysis, Medtronic PLC appears to be potentially undervalued at the current price of $79.75. Our fair value estimate of $71249488674.78 suggests upside potential of approximately 89341051529.8%.
Current Valuation Metrics
Valuation ratios help us understand how the market is pricing MDT relative to its fundamentals. Let's examine the key multiples investors are paying today.
Understanding the Metrics
- P/E Ratio: At 20.90x earnings, MDT is trading near the typical market average of 15-20x.
- P/B Ratio: Book value data not available.
- P/S Ratio: Revenue data not available.
- EV/EBITDA: EBITDA data not available.
Fair Value Estimate
Using a discounted cash flow (DCF) model, we estimate the intrinsic value of Medtronic PLC stock. This fundamental analysis looks at the company's ability to generate future cash flows and discounts them back to today's value.
Our DCF model suggests MDT may be undervalued by approximately 89341051529.8%. This implies the market may be pricing in more pessimistic growth expectations than our base case scenario.
Historical Valuation Trends
Looking at MDT's valuation history helps us understand whether the current multiples are typical or unusual for this company.
MDT's P/E ratio is near its historical average, indicating the market is valuing the company consistently with past trends.
Investment Conclusion
Bottom Line
Based on our comprehensive valuation analysis, Medtronic PLC (MDT) appears to be undervalued at $79.75. With a fair value estimate of $71249488674.78, the stock offers potential upside for long-term investors willing to wait for the market to recognize its intrinsic value.
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.
More Analysis for MDT
Compare with Peers
See how Medtronic PLC stacks up against similar companies
Popular Valuation Analysis
Explore valuation analysis for top stocks
Related: MDT Dividend, MDT Growth, MDT Financial Health
Compare: MDT vs AAPL, MDT vs MSFT, MDT vs GOOGL